Term ends Jan 31, 2032 · Medium confidence
20-year base term ends Jan 31, 2032
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,071,741, US 12,023,342), so the cap could be lower.
Held by Avalyn Pharma Inc.
Filed Jul 7, 2020 as application 16/922,958 · Granted Sep 27, 2022
Base term plus 146 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2012
2032
Clock starts
Jan 31, 2012
Jan 31, 2012
Term ends
Jan 31, 2032
Jan 31, 2032
Granted
Sep 27, 2022
Sep 27, 2022
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
146
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,028,966, US 10,610,536, US 11,071,741, US 11,559,520, US 12,023,342, US 9,770,443.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 146 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 31, 2012, when application 13/363,311, the earliest non-provisional in its chain, was filed (this one was filed Jul 7, 2020) | Jan 31, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +146 days, USPTO patent term adjustment record | Jun 25, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,028,966, US 10,610,536, US 11,071,741, US 11,559,520, US 12,023,342, US 9,770,443) | capped to Jan 31, 2032 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 31, 2032 | Medium confidence |
This family
| US 10,092,552 | In force Apr 2032 | Apr 2032 |
| US 10,105,356 | In force Apr 2032 | Apr 2032 |
| US 11,224,592 | In force Jan 2032 | Jan 2032 |
| Application 16/167,337 | Abandoned not computed | not computed |
| US 11,452,718 | this patent Jan 2032 | Jan 2032 |
| US 11,559,520 | In force Jan 2032 | Jan 2032 |
| Application 17/576,830 | Pending not computed | not computed |
| US 12,226,407 | In force Jan 2032 | Jan 2032 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 7, 2020 Reel 53143, frame 416 | Surber, Mark William | Avalyn Pharma Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jan 2032
Term ends Jan 31, 2032. Maintenance fees still fall due before then
Note
The 146 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,028,966, US 10,610,536, US 11,071,741, US 11,559,520, US 12,023,342, US 9,770,443.
Citations
10
later US patents cite this one
That is top 25% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.